2024-520083-33-00Not yet recruitingPhase 4
Selective laser trabeculoplasty versus eye drops for first line treatment of exfoliation ocular hypertension or glaucoma: a randomised clinical trial
Source: EU CTIS (euclinicaltrials.eu) · Last updated 19 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The main objective of the trial is to show the equilance in efficacy of SLT laser treatment compared to medical therapy as a primary therapy in exfoliation glaucoma.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 112 (estimated)
- First submitted
- 10 Dec 2024
- Start date
- 3 Nov 2020
- Lead sponsor
- HUS-Yhtymae
- Diseases
- Glaucoma
- EU CT number
- 2024-520083-33-00
- EudraCT number
- 2019-004841-34
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 112
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Who cannot take part
Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous intraocular operation excluding uncomplicated cataracta surgery 1 year ago or earlier
Other illness
- Serious other medical condition preventing participation in the trial
- Other active eye disease (active uveitis, clinical significant macular edema, wet AMD, proliferative diabetic retinopathy, intraocular tumor, intraocular injections, IOL luxation)
Other
- Advanced glaucoma
- Participating in other clinical trial
- Target IOP less than 15
- Starting eye pressure 35 or more
- Visual acuity 0.2 or worse
- Angle closure
- Unable to use eye drops
- Significant cataract
Who the study is looking for
- Informed consent
- Age of 50 –100 years
- Possibility to attend 12 months of period
- Exfoliation
- Newly diagnosed exfoliation glaucoma by EGS (European glaucoma society) guidelines or ocular hypertensio TA 24 mmHg or more
- Eye pressure less than 35 mmHg
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| HUS-Yhtymae | Helsinki | Finland | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.